Literature DB >> 15853587

Current approaches to CNS tumors in infants and very young children.

Katherine E Warren1, Roger J Packer.   

Abstract

Treatment of infants and very young children with tumors of the CNS is challenging due to the vulnerability of the developing nervous system. Historically, treatment has relied upon surgery and radiation for control of malignant tumors with limited success and severe long-term consequences in most young patients. More recent studies have attempted to utilize chemotherapy and second-look surgery in attempts to reduce, delay or avoid radiation. Identification of prognostic factors for specific tumor types may distinguish which patients should receive more aggressive therapies and which patients can potentially avoid them and their potential side effects. Achieving successful tumor control while optimizing quality of life for survivors is the major goal of recent research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15853587     DOI: 10.1586/14737175.4.4.681

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  3 in total

1.  Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.

Authors:  André O von Bueren; Katja von Hoff; Torsten Pietsch; Nicolas U Gerber; Monika Warmuth-Metz; Frank Deinlein; Isabella Zwiener; Andreas Faldum; Gudrun Fleischhack; Martin Benesch; Juergen Krauss; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  Intracranial tumors in infants: a single institution experience of 22 patients.

Authors:  Tang-Her Jaing; Chieh-Tsai Wu; Shih-Hsiang Chen; Po-Cheng Hung; Kuang-Lin Lin; Shih-Ming Jung; Chen-Kan Tseng
Journal:  Childs Nerv Syst       Date:  2010-10-08       Impact factor: 1.475

Review 3.  Biologically targeted therapeutics in pediatric brain tumors.

Authors:  Amulya A Nageswara Rao; Joseph Scafidi; Elizabeth M Wells; Roger J Packer
Journal:  Pediatr Neurol       Date:  2012-04       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.